US12565490B2

Inhibitors of Receptor Interacting Protein Kinase I for the treatment of …

University of Texas System

Abstract

Disclosed herein are compounds which inhibit RIPK1, pharmaceutical compositions, and methods of treatment of RIPK1-mediated diseases, such as neurodegenerative disorders, inflammatory disorders, and cancer.

University: University of Texas System
Assignee: Board Of Regents, The University Of Texas System
Inventor: Richard T. Lewis
Priority date: February 28, 2020
Filing date: August 17, 2022
Grant date: March 03, 2026
Publication date: March 03, 2026
Language: en
PDF source: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/12565490
Metadata fetched: August 29, 2026 00:38